ARCHIVES

Novartis Begins Study Of Femara And Zometa In Postmenopausal Early Breast Cancer

This article is from The Cancer Letter archive.

Vol. 25 No. 12 | December 27, 2002

Download PDF Visit The Full Archive

Related Articles

Final Issue Of ‘77

December 16, 1977

A Biostatistics Paper Alleges Potential Harm To Patients In Two Duke Clinical Studies

October 2, 2009

In Brief: HSAs Would Delay NCI Awards By Nine Months; Mary Lasker Names to Carter Health Group

September 17, 1976

AACR 2014 Cancer Progress Report: More Federal Funds Needed

September 19, 2014

NCI Director Among Bush Appointees Asked To Submit Resignation.

December 12, 2008

Funding Opportunities

March 7, 2003